RFG Advisory’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.62M | Buy |
52,401
+3,591
| +7% | +$248K | 0.09% | 186 |
|
|
2025
Q1 | $3.39M | Buy |
48,810
+36,786
| +306% | +$2.55M | 0.09% | 159 |
|
|
2024
Q4 | $1.03M | Sell |
12,024
-8,304
| -41% | -$714K | 0.03% | 359 |
|
|
2024
Q3 | $2.42M | Buy |
20,328
+9,205
| +83% | +$1.1M | 0.07% | 207 |
|
|
2024
Q2 | $1.59M | Buy |
11,123
+381
| +4% | +$54.4K | 0.05% | 267 |
|
|
2024
Q1 | $1.38M | Buy |
10,742
+4,835
| +82% | +$621K | 0.05% | 289 |
|
|
2023
Q4 | $611K | Sell |
5,907
-1,132
| -16% | -$117K | 0.02% | 402 |
|
|
2023
Q3 | $640K | Sell |
7,039
-367
| -5% | -$33.4K | 0.03% | 361 |
|
|
2023
Q2 | $599K | Buy |
7,406
+174
| +2% | +$14.1K | 0.03% | 385 |
|
|
2023
Q1 | $575K | Sell |
7,232
-98
| -1% | -$7.8K | 0.03% | 380 |
|
|
2022
Q4 | $501K | Sell |
7,330
-32
| -0.4% | -$2.19K | 0.03% | 403 |
|
|
2022
Q3 | $423K | Buy |
7,362
+184
| +3% | +$10.6K | 0.02% | 416 |
|
|
2022
Q2 | $370K | Buy |
7,178
+14
| +0.2% | +$722 | 0.02% | 414 |
|
|
2022
Q1 | $398K | Buy |
7,164
+124
| +2% | +$6.89K | 0.03% | 365 |
|
|
2021
Q4 | $394K | Sell |
7,040
-30
| -0.4% | -$1.68K | 0.03% | 344 |
|
|
2021
Q3 | $339K | Buy |
7,070
+22
| +0.3% | +$1.06K | 0.03% | 328 |
|
|
2021
Q2 | $295K | Sell |
7,048
-120
| -2% | -$5.02K | 0.03% | 358 |
|
|
2021
Q1 | $242K | Buy |
7,168
+184
| +3% | +$6.21K | 0.03% | 383 |
|
|
2020
Q4 | $245K | Sell |
6,984
-400
| -5% | -$14K | 0.03% | 381 |
|
|
2020
Q3 | $256K | Sell |
7,384
-108
| -1% | -$3.74K | 0.04% | 349 |
|
|
2020
Q2 | $245K | Buy |
7,492
+90
| +1% | +$2.94K | 0.04% | 329 |
|
|
2020
Q1 | $223K | Sell |
7,402
-22
| -0.3% | -$663 | 0.04% | 306 |
|
|
2019
Q4 | $215K | Sell |
7,424
-900
| -11% | -$26.1K | 0.04% | 334 |
|
|
2019
Q3 | $215K | Sell |
8,324
-138
| -2% | -$3.56K | 0.04% | 302 |
|
|
2019
Q2 | $216K | Buy |
+8,462
| New | +$216K | 0.05% | 291 |
|